About this trial
Colorectal cancer (CRC) is the third most diagnosed cancer in Canada. The most common surgical procedure in patients with CRC is an intestinal resection followed by a reconnection to rejoin the ends of the remaining bowel. Among the postoperative complications, leaking of this intestinal connection is notably feared, affecting up to 20% of patients. These leaks are characterized by impaired intestinal healing and are associated with severe infections and even death.
Various studies have shown that gut microbiota, the bacteria that live in the digestive tract, plays an essential role in intestinal healing following surgery. These results support the possibility of enhancing intestinal healing through supplements that act as an energy source for gut bacteria. Indeed, animal studies have shown that inulin supplementation, a fiber commonly found in plants, improves intestinal healing following bowel surgery. However, no studies in humans have evaluated its effects on CRC surgery patients.
This study aims to determine feasibility of a randomized controlled trial that assesses the effects of inulin supplementation before elective colorectal surgery.
Eligibility criteria
Qualifiers
Patients with a colorectal cancer and who present for elective colorectal surgery
Disqualifiers
Emergency surgery for perforation/obstruction.
Use of antibiotics within 4 weeks prior to surgery (other than usual antibiotic prophylaxis).
Presence of preoperative ileostomy or colostomy.
Intestinal surgery within 4 weeks prior to colonic surgery.
Trial design
Treatments tested in this trial
- Inulin
- Placebo